Development of lead compounds for trypanocidal drugs based on inhibitors targeted against parasite glycolysis

Informazioni relative al progetto

QUINONES WILFREDO

ID dell’accordo di sovvenzione: ICB1-CT-2001-80008

Progetto chiuso

Data di avvio 1 Giugno 2000

Data di completamento 30 Novembre 2000

Finanziato da

• Programme for research, technological development and demonstration on "Confirming the international role of Community research,1998-2002"

Costo totale € 31 200,00

Contributo UE € 31 200,00

Coordinato da

CHRISTIAN DE DUVE INSTITUTE OF CELLULAR PATHOLOGY
Belgium

Obiettivo

Cloning, over-expression of one gene of interest of Leishmania Mexican and validation as drug target (PGAM, FR).General training in Molecular Biology and work in the corresponding INCO project

Campo scientifico

• natural sciences › biological sciences › molecular biology

Programma(i)

• FP5-INCO 2 - Programme for research, technological development and demonstration on "Confirming the international role of Community research,1998-2002"

Argomento(i)

• 1.2.1.-2. - Training for researchers

Invito a presentare proposte

Data not available

Meccanismo di finanziamento

RGI - Research grants (individual fellowships)

Coordinatore

CHRISTIAN DE DUVE INSTITUTE OF CELLULAR PATHOLOGY

• Contributo UE: Nessun dato
• Indirizzo: 74,Avenue Hippocrate 74, ICP-TROP 74.39 ; 1200 BRUXELLES ; Belgio
• Costo totale: Nessun dato